Literature DB >> 3665983

Imaging in plague.

A J Moreno1, T A Reeves, A A Rodriguez, G L Turnbull.   

Abstract

An 8-year-old boy presented with elevated temperature, malaise, hepatosplenomegaly, mesenteric adenitis, and septic shock. Cultures of biopsied abdominal lymph nodes as well as the blood grew Yersinia pestes. The boy's condition improved after two weeks of chloramphenicol and cefotaxime (Claforan). Two days after stopping intravenous antibiotic therapy, the patient again became febrile and complained of abdominal pain. Abdominal imaging with 111In-labeled leukocytes did not show any abnormalities, however, 67Ga-citrate scintigraphy demonstrated an abnormal focus of increased radiopharmaceutical uptake within a confluence of necrosed lymph nodes within the right upper quadrant of the abdomen. In addition, abnormal 67Ga-uptake was seen within the left hip region. Correlative imaging with computed tomography is also presented.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3665983     DOI: 10.1007/bf00256560

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  5 in total

1.  Plague and the gallium scan: Case report.

Authors:  T L Stahly; J D Shoop
Journal:  J Nucl Med       Date:  1975-11       Impact factor: 10.057

2.  Epidemiologic and clinical features of an outbreak of bubonic plague in New Mexico.

Authors:  C F von Reyn; N S Weber; B Tempest; A M Barnes; J D Poland; J M Boyce; V Zalma
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

Review 3.  Bubonic plague in the Southwestern United States. A review of recent experience.

Authors:  W P Reed; D L Palmer; R C Williams; A L Kisch
Journal:  Medicine (Baltimore)       Date:  1970-11       Impact factor: 1.889

4.  Plague--perspectives on a rare disease.

Authors:  J Mann
Journal:  West J Med       Date:  1984-04

5.  Comparisons of scintigraphy with In-111 leukocytes and Ga-67 in the diagnosis of occult sepsis.

Authors:  G N Sfakianakis; W Al-Sheikh; A Heal; G Rodman; R Zeppa; A Serafini
Journal:  J Nucl Med       Date:  1982-07       Impact factor: 10.057

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.